ERMAP
Erythroid membrane-associated protein
Also known as: BTN5, ERMAP_HUMAN, RD, SC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96PL5
- Gene
- ERMAP
- Ensembl
- ENSG00000164010
- Chromosome
- 1
- Canonical length
- 475 aa
- Protein class
- Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Golgi apparatus,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a cell surface transmembrane protein that may act as an erythroid cell receptor, possibly as a mediator of cell adhesion. Polymorphisms in this gene are responsible for the Scianna/Radin blood group system. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
475 residues, UniProt reviewed canonical sequence.
>Q96PL5|ERMAP
1 MEMASSAGSW LSGCLIPLVF LRLSVHVSGH AGDAGKFHVA LLGGTAELLC PLSLWPGTVP
61 KEVRWLRSPF PQRSQAVHIF RDGKDQDEDL MPEYKGRTVL VRDAQEGSVT LQILDVRLED
121 QGSYRCLIQV GNLSKEDTVI LQVAAPSVGS LSPSAVALAV ILPVLVLLIM VCLCLIWKQR
181 RAKEKLLYEH VTEVDNLLSD HAKEKGKLHK AVKKLRSELK LKRAAANSGW RRARLHFVAV
241 TLDPDTAHPK LILSEDQRCV RLGDRRQPVP DNPQRFDFVV SILGSEYFTT GCHYWEVYVG
301 DKTKWILGVC SESVSRKGKV TASPANGHWL LRQSRGNEYE ALTSPQTSFR LKEPPRCVGI
361 FLDYEAGVIS FYNVTNKSHI FTFTHNFSGP LRPFFEPCLH DGGKNTAPLV ICSELHKSEE
421 SIVPRPEGKG HANGDVSLKV NSSLLPPKAP ELKDIILSLP PDLGPALQEL KAPSFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ERMAP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 29 nTPM
- epididymis: 15 nTPM
- liver: 12 nTPM
- thyroid gland: 12 nTPM
- fallopian tube: 9.5 nTPM
- pancreas: 8.9 nTPM
Single-cell type
- erythrocyte progenitors: 99 nCPM
- microglia: 85 nCPM
- late spermatids: 66 nCPM
- epididymal principal cells: 57 nCPM
- corticotrophs: 51 nCPM
- adrenal cortex cells: 48 nCPM
Immune cell
- myeloid DC: 5.1 nTPM
- intermediate monocyte: 4.5 nTPM
- classical monocyte: 4.3 nTPM
- T-reg: 3.2 nTPM
- non-classical monocyte: 3.1 nTPM
- NK-cell: 2.2 nTPM
Brain region
- medulla oblongata: 8.4 nTPM
- hypothalamus: 8.3 nTPM
- white matter: 8 nTPM
- choroid plexus: 7.6 nTPM
- thalamus: 7.4 nTPM
- midbrain: 7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ERMAP.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 88 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- SCIANNA BLOOD GROUP SYSTEM, SC:-1,-2
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.17
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.71
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- B30.2/SPRY domain
- Immunoglobulin domain subtype
- SPRY domain
- Butyrophylin-like, SPRY domain
- SPRY-associated
- Immunoglobulin-like domain
- Immunoglobulin V-set domain
- Concanavalin A-like lectin/glucanase domain superfamily
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- B30.2/SPRY domain superfamily
- Tripartite motif-containing
- SPRY domain
- Immunoglobulin V-set domain
- SPRY-associated domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ERMAP as an antibody target. Whether an autoantibody or antibody against ERMAP could matter depends on whether native ERMAP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ERMAP is annotated at the cell surface, where native ERMAP is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ERMAP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...